Literature DB >> 22407432

Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to 'buzz' smoke by HPLC/MS/MS.

Justin L Poklis1, Dorra Amira, Laura E Wise, Jason M Wiebelhaus, Brenda J Haggerty, Aron H Lichtman, Alphonse Poklis.   

Abstract

The disposition of the cannabimimetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mice following inhalation of the smoke of the herbal incense product (HIP) 'Buzz' is presented. A high-pressure liquid chromatography with electrospray ionization triple quadrupole mass spectrometer (HPLC/MS/MS) method was validated for the analysis of JWH-018 in the specimens using deuterated Δ(9) -tetrahydrocannabinol (d(3) -THC) as the internal standard. JWH-018 was isolated by cold acetonitrile liquid-liquid extraction. Chromatographic separation was performed on a Zorbaz eclipse XDB-C(18) column. The assay was linear from 1 to 1000 ng/mL. Six C57BL6 mice were sacrificed 20 min after exposure to the smoke of 200 mg 'Buzz' containing 5.4% JWH-018. Specimen concentrations of JWH-018 were: blood, 54-166 ng/mL (mean 82 ± 42 ng/mL); brain, 316-708 ng/g (mean 510 ± 166 ng/g); and liver, 1370-3220 ng/mL (mean 1990 ± 752 ng/mL). The mean blood to brain ratio for JWH-018 was 6.8 and ranged from 4.2 to 10.9. After exposure, the responses of the mice were consistent with cannabinoid receptor type 1 activity: body temperatures dropped 7.3 ± 1.1 °C, and catalepsy, hyperreflexia, straub tail and ptosis were observed. The brain concentrations and physiological responses are consistent with the hypothesis that the behavioral effects of 'Buzz' are attributable to JWH-018.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407432      PMCID: PMC3697740          DOI: 10.1002/bmc.2710

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  31 in total

1.  Identification of a cannabinoid analog as a new type of designer drug in a herbal product.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Nobuo Kawahara; Yuji Haishima; Yukihiro Goda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2009-04       Impact factor: 1.645

2.  Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures.

Authors:  Andrej Grigoryev; Sergey Savchuk; Aleksandra Melnik; Natal'ja Moskaleva; Jurij Dzhurko; Mihail Ershov; Aleksandr Nosyrev; Aleksandr Vedenin; Boris Izotov; Irina Zabirova; Vladimir Rozhanets
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-26       Impact factor: 3.205

3.  The pharmacological activity of inhalation exposure to marijuana smoke in mice.

Authors:  A H Lichtman; J L Poklis; A Poklis; D M Wilson; B R Martin
Journal:  Drug Alcohol Depend       Date:  2001-07-01       Impact factor: 4.492

4.  Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Jun Ogata; Yukihiro Goda
Journal:  Forensic Sci Int       Date:  2010-05-20       Impact factor: 2.395

5.  Interactions between THC and cannabidiol in mouse models of cannabinoid activity.

Authors:  S A Varvel; J L Wiley; R Yang; D T Bridgen; K Long; A H Lichtman; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  2006-03-30       Impact factor: 4.530

6.  Disposition of cannabichromene, cannabidiol, and Δ⁹-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Justin L Poklis; Candace C Thompson; Kelly A Long; Aron H Lichtman; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2010-10       Impact factor: 3.367

7.  Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Authors:  P J Little; D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

8.  Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.

Authors:  A Weissman; G M Milne; L S Melvin
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

9.  A pharmacological analysis of levonantradol antinociception in mice.

Authors:  J J Jacob; K Ramabadran; M Campos-Medeiros
Journal:  J Clin Pharmacol       Date:  1981 Aug-Sep       Impact factor: 3.126

10.  Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents.

Authors:  D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1992-01       Impact factor: 4.030

View more
  5 in total

1.  Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice.

Authors:  Jason M Wiebelhaus; Justin L Poklis; Alphonse Poklis; Robert E Vann; Aron H Lichtman; Laura E Wise
Journal:  Drug Alcohol Depend       Date:  2012-07-07       Impact factor: 4.492

2.  Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain.

Authors:  Kimberly L Samano; Justin L Poklis; Aron H Lichtman; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2014-05-09       Impact factor: 3.367

3.  Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs.

Authors:  Nadine Schaefer; Mattias Kettner; Matthias W Laschke; Julia Schlote; Andreas H Ewald; Michael D Menger; Hans H Maurer; Peter H Schmidt
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  Is adipose tissue suitable for detection of (synthetic) cannabinoids? A comparative study analyzing antemortem and postmortem specimens following pulmonary administration of JWH-210, RCS-4, as well as ∆9-tetrahydrocannabinol to pigs.

Authors:  Nadine Schaefer; Frederike Nordmeier; Ann-Katrin Kröll; Christina Körbel; Matthias W Laschke; Michael D Menger; Hans H Maurer; Markus R Meyer; Peter H Schmidt
Journal:  Arch Toxicol       Date:  2020-07-14       Impact factor: 5.153

5.  The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.

Authors:  Kristen R Trexler; S Olivia Vanegas; Justin L Poklis; Steven G Kinsey
Journal:  Drug Alcohol Depend       Date:  2020-07-15       Impact factor: 4.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.